Sanomedics International Holdings Inc. Continues To Move Forward With Their Strategic Growth Plans

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIAMI, May 6, 2014 /PRNewswire/ -- Sanomedics International Holdings, Inc. (OTCQB: SIMH) (“Sanomedics”), a medical technology holding company that focuses on game-changing products, services and ideas, today announced that they continue to move forward with their aggressive growth strategy of acquiring existing businesses that generate revenue and anticipate will be accretive to earnings, as well as continue to foster the organic growth of the existing business.

Keith Houlihan, President of Sanomedics International Holdings, Inc., said We continue to make progress in the execution of expanding our portfolio of identifiable medical technology and service businesses and potentially grow shareholder value. We will continue to update our shareholders as new developments unfold.”

About Sanomedics International Holdings, Inc.

Sanomedics International Holdings, Inc. (OTCQB: SIMH) is a medical technology holding company that focuses on game changing products, services and ideas - a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. We plan to grow our existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.

Forward Looking Statements

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company’s periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

Contact:

Keith Houlihan

305-433-7814

SOURCE Sanomedics International Holdings, Inc.

Help employers find you! Check out all the jobs and post your resume.